文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Quantitative MRI for Early Treatment Response in MASLD.

作者信息

Yin Meng

机构信息

Department of Radiology, Mayo Clinic, 200 First St SW, Rochester, MN 55905.

出版信息

Radiology. 2025 Aug;316(2):e252218. doi: 10.1148/radiol.252218.

DOI:10.1148/radiol.252218
PMID:40828045
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12405706/
Abstract
摘要

相似文献

[1]
Quantitative MRI for Early Treatment Response in MASLD.

Radiology. 2025-8

[2]
Inflammatory markers as diagnostic and precision nutrition tools for metabolic dysfunction-associated steatotic liver disease: Results from the Fatty Liver in Obesity trial.

Clin Nutr. 2024-7

[3]
Impact of alcohol consumption and muscle mass on bone mineral density in metabolic dysfunction and alcohol-associated liver disease (MetALD) and metabolic dysfunction-associated steatotic liver disease (MASLD).

Clin Nutr ESPEN. 2025-7-7

[4]
Screening for MASLD in patients with type 2 diabetes: is an early diagnosis a good diagnosis?

Expert Rev Gastroenterol Hepatol. 2025-9

[5]
Nonalcoholic Fatty Liver

2025-1

[6]
Proton density fat fraction for diagnosis of metabolic dysfunction-associated steatotic liver disease.

Hepatology. 2025-3-25

[7]
Weight gain in infancy and metabolic dysfunction-associated steatotic liver disease (MASLD) in a prospective birth cohort of Latino children.

Matern Health Neonatol Perinatol. 2025-8-15

[8]
(-)Epicatechin targets early growth response protein 1, an inflammation-associated ferroptosis regulator, to ameliorate metabolic dysfunction-associated steatotic liver disease.

Biochem Pharmacol. 2025-7-4

[9]
Validation of FIB-4 for the Diagnosis of Liver Cirrhosis in Metabolic Dysfunction-Associated Steatotic Liver Disease.

Can Liver J. 2025-2-12

[10]
Impact of weight loss and lifestyle modifications on liver fibrosis in MASLD and MetALD: A cohort study.

Biomed Rep. 2025-7-25

本文引用的文献

[1]
Multiparametric MRI Evaluation of Liver Fat and Iron after Glucagon-like Peptide-1 Receptor and Glucagon Receptor Dual-Agonist Treatment in a High-Fat Diet-induced Mouse Model.

Radiology. 2025-8

[2]
Multi-Center, Multi-Vendor Validation of Simultaneous MRI-Based Proton Density Fat Fraction and R2* Mapping Using a Combined Proton Density Fat Fraction-R2* Phantom.

J Magn Reson Imaging. 2025-4-18

[3]
Extracellular Vesicles miRNome Profiling Reveals miRNAs Engagement in Dysfunctional Lipid Metabolism, Chronic Inflammation and Liver Damage in Subjects With Metabolic Dysfunction-Associated Steatotic Liver Disease.

Aliment Pharmacol Ther. 2025-7

[4]
Three-Dimensional Vector MR Elastography for Evaluating Tissue Mechanical Heterogeneity to Assess Liver Disease Progression.

Radiology. 2025-4

[5]
Addressing the High and Rising Global Burden of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH): From the Growing Prevalence to Payors' Perspective.

Aliment Pharmacol Ther. 2025-5

[6]
Resmetirom therapy for metabolic dysfunction-associated steatotic liver disease: October 2024 updates to AASLD Practice Guidance.

Hepatology. 2025-1-1

[7]
Impact of age on NIS2+™ and other non-invasive blood tests for the evaluation of liver disease and detection of at-risk MASH.

JHEP Rep. 2024-1-19

[8]
Computed tomography-based evaluation of segmental variation of liver density and its implications.

Indian J Gastroenterol. 2020-2

[9]
Inter-examination precision of magnitude-based MRI for estimation of segmental hepatic proton density fat fraction in obese subjects.

J Magn Reson Imaging. 2014-5

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索